# SurvivorNet

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/survivornet

- Industry: Media
- Headquarters: New York, US
- Website: www.survivornet.com
- Total disclosed funding: $10M
- Latest round: Series B (Jan 10, 2020)
- Investors on record: 1

## About

SurvivorNet, Inc. is a digital health company dedicated to providing personalized cancer treatment guidance and resources through an AI-driven platform, enhancing the support available to patients and their families.SurvivorNet, Inc. specializes in offering digital resources for individuals affected by cancer. The company is headquartered in New York, US, and was founded by Steve Alperin, who has previous entrepreneurial experience. In January 2020, SurvivorNet raised USD 10 mn in a SERIES B funding round led by Gatemore Ventures, bringing the total amount raised to USD 10 mn.SurvivorNet provides a comprehensive suite of digital resources for individuals impacted by cancer, featuring an AI-driven platform that offers personalized guidance on treatment options, clinical trials, and support resources. Users benefit from interactive health panels and chat features tailored to their health profiles, alongside expert-curated educational guides designed for patients and caregivers navigating cancer diagnoses and treatment pathways. The platform serves cancer patients, their families, and healthcare providers, primarily in the US, with plans for international expansion.SurvivorNet generates revenue through subscription services and partnerships with healthcare organizations. Clients, including patients and caregivers, pay for access to premium content and tools that aid in informed healthcare decisions. The platform collaborates with medical professionals and institutions to provide direct-to-consumer access to clinical trial information and educational resources, supported by various subscription tiers based on user engagement and needs.Looking ahead, SurvivorNet plans to leverage its recent SERIES B funding of USD 10 mn raised in January 2020 to enhance its platform capabilities and expand into new markets. The company is focused on developing additional features and products aimed at improving user experience and engagement, with particular emphasis on international markets where cancer support resources may be limited. Specific release dates for new products have not been disclosed, but the company's strategic direction indicates a commitment to broadening its reach in the healthcare sector.

## Funding rounds

- Series B, Jan 10, 2020, $10M — Gatemore Ventures

## Investors

- Gatemore Ventures (https://capitalatlas.ai/funds/gatemore-ventures) — Series B